Tag : Latanoprost Ophthalmic Solution

Glenmark Pharmaceuticals Inc., USA launches Latanoprost Ophthalmic Solution, 0.005% (0.05 mg/mL)

NewsmantraFebruary 14, 2025

Bengaluru, February 14, 2025 – Glenmark Pharmaceuticals Inc., USA (Glenmark) is pleased to announce the launch1 of...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More